Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Autolus Therapeutics (AUTL) Return on Equity: 2018-2025

Historic Return on Equity for Autolus Therapeutics (AUTL) over the last 5 years, with Sep 2025 value amounting to -0.73%.

  • Autolus Therapeutics' Return on Equity fell 20.00% to -0.73% in Q3 2025 from the same period last year, while for Sep 2025 it was -0.73%, marking a year-over-year decrease of 20.00%. This contributed to the annual value of -0.82% for FY2024, which is 20.00% up from last year.
  • Latest data reveals that Autolus Therapeutics reported Return on Equity of -0.73% as of Q3 2025, which was down 15.73% from -0.63% recorded in Q2 2025.
  • In the past 5 years, Autolus Therapeutics' Return on Equity registered a high of -0.42% during Q2 2024, and its lowest value of -184.68% during Q2 2022.
  • Over the past 3 years, Autolus Therapeutics' median Return on Equity value was -0.63% (recorded in 2023), while the average stood at -0.67%.
  • As far as peak fluctuations go, Autolus Therapeutics' Return on Equity slumped by 18,406bps in 2022, and later soared by 18,406bps in 2023.
  • Autolus Therapeutics' Return on Equity (Quarterly) stood at -160.77% in 2021, then surged by 16,012bps to -0.65% in 2022, then tumbled by 78bps to -1.43% in 2023, then surged by 94bps to -0.49% in 2024, then decreased by 20bps to -0.73% in 2025.
  • Its Return on Equity stands at -0.73% for Q3 2025, versus -0.63% for Q2 2025 and -0.60% for Q1 2025.